Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Exanthema × Doxycycline × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Exanthema 1 Colonic Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Sirolimus 1 Panitumumab 1 Irinotecan 1 IFL protocol 1 Gels 1 Doxycycline 1 Dapsone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02239731 2018-02-27

Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Vyne Therapeutics Inc.

Phase 2 Completed

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡